Lapsi Health Unveils Keikku 2.0: World’s First FDA-Cleared Digital Stethoscope
The first multimodal device that merges auscultation, documentation, and AI analysis into one seamless workflow
Lapsi Health Launches Keikku 2.0: World’s First FDA-Cleared Digital Stethoscope with Built-in AI Scribe and Diagnostics
Lapsi Health launched Keikku 2.0, a digital stethoscope that combines real-time auscultation, AI-powered diagnostics, and automatic medical scribing in a single device. The product is now available for clinicians across the U.S. and Europe.
Keikku 2.0 is the first FDA-cleared multimodal stethoscope to integrate clinical listening, automatic documentation, and diagnostic support in real time—marking a significant advancement in digital medicine.
“For the first time, physicians can listen, document, and diagnose in real time with a single device,” said Dr. Jhonatan Bringas Dimitriades, CEO and co-founder of Lapsi Health. “That means less time on paperwork and more focus on patients. We’re proud to bring this innovation to market and give clinicians back hours each day to deliver better patient care.”
A Game-Changer for Clinical Workflows
In primary care, physicians currently spend an average of 36 minutes per patient visit on charting within electronic health records (EHRs), according to the American Medical Association. Keikku 2.0 aims to dramatically reduce this burden.
The device automatically generates ready-to-use clinical notes and integrates directly with major EHR systems. Unlike other devices, Keikku 2.0 is compatible with all major AI scribe technologies, including its own proprietary Keikku AI as well as leading third-party platforms. All data is secured with end-to-end encryption and HIPAA-compliant protocols, ensuring patient privacy.
Real-Time AI Diagnostics
Beyond documentation, Keikku 2.0 also acts as a clinical decision support tool. The device’s AI-powered auscultation engine analyzes heart and lung sounds in real time to detect anomalies such as murmurs or pulmonary abnormalities — delivering instant, data-driven insights during routine exams.
Its high-definition ambient microphones ensure precise sound capture even in noisy environments, while advanced sensors convert sound into structured clinical data for more personalized care.
Physician-Designed, Field-Ready
Built by physicians for clinicians, Keikku 2.0 is a Class II wireless medical device designed to seamlessly fit into everyday workflows. Lightweight and portable, it is ideal for use during hospital rounds, in exam rooms, or even in the field.
“We designed Keikku 2.0 to fit naturally into clinical workflows,” said Dr. Diana van Stijn, Chief Medical Officer and co-founder of Lapsi Health. “Every feature is about improving efficiency and reducing stress, so clinicians can focus on their patients.”
Currently, Keikku 2.0 connects via Bluetooth to a smartphone. Lapsi Health plans to release future models with full standalone capabilities.
What the Medical Community Is Saying
The medical community has already begun praising Keikku 2.0 as a transformative tool:
- Dr. Shafi Ahmed, Professor and Surgeon, London: “Just as Apple reimagined the phone, Keikku redefines listening to voice and the human body. It’s not just a tool — it’s a Medical Assistant.”
- Dr. Carlos Sendon, Pulmonologist, Washington, DC: “A powerful tool to carry unlimited AI into my clinical practice, so I can use it responsibly.”
- Dr. Tamara Sunbul, CMIO, Riyadh: “Keikku has completely transformed the way I approach workflow and auscultation in my daily practice.”
Availability and Ordering
Keikku 2.0 is available now. Clinicians and health systems can place orders or learn more at www.keikku.health.
About Lapsi Health
Founded by physicians and entrepreneurs Dr. Jhonatan Bringas Dimitriades, Dr. Diana van Stijn, Rodrigo Alvez, and Seamus Holohan, Lapsi Health is a global health tech company headquartered in Amsterdam and Houston. The company is redefining frontline care by transforming traditional medical tools into AI-powered diagnostic platforms.
Backed by Modi Ventures, 1921 VC, and Mentors Fund, Lapsi Health’s mission is to improve medical efficiency, accuracy, and the patient-provider experience. Keikku is its flagship platform and the first FDA-cleared stethoscope to integrate AI diagnostics and automated documentation into a single, easy-to-use device.